Clinical Trial Update: Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the use of dapagliflozin in patients with refractory heart failure is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia | Conditions: Heart Failure | Phase 4 | Status: RECRUITING